For the Inventor, By the Inventor

Enter assignee name

Pittsburgh, PA, United States of America

Precision Therapeutics, Inc.

USPTO Granted Patents = 21

% Expired Patents = 66.7

EPO Patents = 1

Trademarks = 5

Forward Citations = 428

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Paul L Kornblith (17 out of 17 patents)

Sean McDonald (5 out of 5 patents)

Michael J Gabrin (2 out of 4 patents)

4. Stacey Brower (2 out of 2 patents)

5. Payal Nanavati (2 out of 2 patents)

6. Holly Gallion (2 out of 2 patents)

7. Shara Dawn Rice (2 out of 2 patents)

8. Anuja Chattopadhyay (2 out of 2 patents)

9. Zhibao Mi (1 out of 3 patents)

10. Dave Gingrich (1 out of 1 patent)

11. Mike Gabrin (1 out of 1 patent)

12. Sheri Gimigliano (1 out of 1 patent)

13. Michael W Zislis (1 out of 1 patent)

21 patents: Sort by Forward Citations

1. 8236489 - Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics (2012-08-07),

2. 8187800 - Methods for selecting active agents for cancer treatment (2012-05-29),

3. 8183009 - Assaying cellular markers for the evaluation of tumors (2012-05-22),

4. 8058025 - Methods for determining efficacy of chemotherapeutic agents (2011-11-15),

5. 8039213 - Methods for assessing efficacy of chemotherapeutic agents (2011-10-18),

6. 7972769 - Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays (2011-07-05),

7. 7829288 - Methods for assessing efficacy of chemotherapeutic agents (2010-11-09),

8. 7771963 - Methods for determining efficacy of chemotherapeutic agents (2010-08-10),

9. 7678552 - Method for selecting therapeutic agents for cancer treatment (2010-03-16),

10. 7642048 - Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics (2010-01-05),

11. 7575868 - Methods for assessing efficacy of chemotherapeutic agents (2009-08-18),

12. 7563593 - Method for preparing cell cultures from biological specimens for assaying secreted factors (2009-07-21),

13. 7501260 - Methods for determining efficacy of chemotherapeutic agents for a patient prior to treatment (2009-03-10),

14. 7314731 - Method for selecting therapeutic agents for cancer (2008-01-01),

15. 7112415 - Method of preparing cell cultures from biological specimens for assaying a response to an agent (2006-09-26),

Company Overview

Precision Therapeutics, Inc. is a biotechnology company based in Pittsburgh, Pennsylvania, focused on developing innovative solutions for cancer treatment. The organization specializes in personalized medicine, utilizing advanced technologies to analyze patient-specific tumor characteristics. This approach aims to enhance therapeutic efficacy and improve patient outcomes. Precision Therapeutics is committed to advancing the field of oncology through its research and development efforts, contributing to the growing landscape of targeted therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

21 Patents

#113 in Pittsburgh, PA

#571 in Pennsylvania

#15,712 in US

#30,001 in the World

Pittsburgh, PA, United States of America

Precision Therapeutics, Inc.

Forward Citations = 428

13 inventors:

Paul L Kornblith (17 out of 17 patents)

Sean McDonald (5 out of 5 patents)

Michael J Gabrin (2 out of 4 patents)

4. Stacey Brower (2 out of 2 patents)

5. Payal Nanavati (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Precision Therapeutics, Inc.. Retrieved from https://idiyas.com/company/precision-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…